Aptamer-functionalized peptide H3CR5C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma
Ying Liu,1,* Xin Wu,1,* Yuan Gao,2,* Jigang Zhang,1 Dandan Zhang,1 Shengying Gu,1 Guanhua Zhu,1 Gaolin Liu,1 Xiaoyu Li1 1Department of Clinical Pharmacy, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, 2Department of Pharmaceutics, Changhai Hospital, Second Military Medic...
Main Authors: | Liu Y, Wu X, Gao Y, Zhang JG, Zhang DD, Gu SY, Zhu GH, Liu GL, Li XY |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-08-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/aptamer-functionalized-peptide-h3cr5c-as-a-novel-nanovehicle-for-codel-peer-reviewed-article-IJN |
Similar Items
-
Fasudil inhibits actin polymerization and collagen synthesis and induces apoptosis in human urethral scar fibroblasts via the Rho/ROCK pathway
by: Li XD, et al.
Published: (2018-09-01) -
Fasudil Increased the Sensitivity to Gefitinib in NSCLC by Decreasing Intracellular Lipid Accumulation
by: Tingting Liao, et al.
Published: (2022-09-01) -
Alleviation of the doxorubicin-induced nephrotoxicity by fasudil in vivo and in vitro
by: Chengyu Xiang, et al.
Published: (2021-01-01) -
Hydrochloride fasudil attenuates brain injury in ICH rats
by: Li Limin, et al.
Published: (2020-04-01) -
Fasudil inhibits proliferation and migration of Hep-2 laryngeal carcinoma cells
by: Zhang X, et al.
Published: (2018-02-01)